Clinical trial Recruiting at 1 site Observational Ages 22 to 75

Observing the effects of Pipeline embolization on intracranial aneurysms

Official title: Pipeline Embolization Device for Intracranial Aneurysm (PEDIA): a Prospective, Multicenter Cohort Focus on Safety, Efficacy, and Haemodynamics

Run by Zhujiang Hospital · NCT06446778 · Data updated 2026-11-12

This study looks at how well the Pipeline device works and its safety for people with brain aneurysms who have had it implanted.

More Hemodynamic Instability trials

Quick facts

Study typeObservational
Ages22 Years to 75 Years
SexAll
Enrollment1000 (estimated)
SponsorZhujiang Hospital
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedSeptember 1, 2022
Main results expectedSeptember 1, 2027
Study endsSeptember 1, 2030
Registry record updatedNovember 18, 2024
Trial IDNCT06446778 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 22 to 75 with diagnosed unruptured intracranial aneurysms suitable for Pipeline embolization.

Probably not a fit

Patients with contraindications to flow-diversion treatment, other significant vascular lesions, or those who are pregnant or lactating may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects clinical, laboratory, and imaging data from patients with intracranial aneurysms who have undergone Pipeline implantation. The aim is to evaluate the safety and efficacy of the Pipeline embolization device, focusing on aneurysmal occlusion status, incidence of in-stent stenosis, and functional prognosis. Additionally, the study assesses hemodynamic changes before and after the stent implantation. The data gathered will help in understanding the outcomes associated with this treatment approach.

Why it matters

Potential benefit: If successful, this study could improve treatment strategies for patients with intracranial aneurysms, potentially leading to better outcomes and reduced complications.

How similar studies have gone: Other studies using flow-diverter devices for treating intracranial aneurysms have shown promising results, indicating that this approach is supported by prior evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

1. Aged 22 to 75 years old, male or non-pregnant female;
2. UIA was diagnosed by CTA, MRA, or DSA;
3. The size of aneurysms is between 3 to 25mm;
4. Understands the nature of the procedure and provision of written informed consent;
5. Indications for FD implantation with or without adjunctive coiling;
6. Is willing to return to the investigational site for follow-up according to our protocol.

Exclusion criteria:

1. With contraindications to flow-diversion treatment or known allergy to cobalt-chromium alloy or contrast medium;
2. Pregnancy or lactation;
3. Coexist with other vascular lesions (coronary artery disease, abdominal aortic aneurysm, severe intracranial artery stenosis, arteriovenous malformation, dural arteriovenous fistula, Moyamoya disease, etc.);
4. Parent vessel with a diameter \<2.0 mm or ≥5.0 mm.;
5. Unwilling to be followed up or likely to have poor treatment compliance;
6. Life expectancy less than 3 years;
7. Inability to receive anti-platelet or anticoagulant medication;
8. Severe neurological deficit that renders the patient unable to live independently (modified Rankin score ≥4);
9. Enrollment in another trial or other situations that the researcher deems unsuitable for inclusion in the study.

Where it's running

  • Zhujiang hospital
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.